Richard Byrd, the EVP & President Interventional of $BDX, sold 459 shares of the company on 03-18-2025 for an estimated $105,570. We received data on the trade from a recent SEC filing. This was a sale of approximately 6.2% of their shares of this class of stock. Following this trade, they now own 6,952 shares of this class of $BDX stock.
$BDX Insider Trading Activity
$BDX insiders have traded $BDX stock on the open market 13 times in the past 6 months. Of those trades, 1 have been purchases and 12 have been sales.
Here’s a breakdown of recent trading of $BDX stock by insiders over the last 6 months:
- ROLAND GOETTE (EVP and President, EMEA) has made 0 purchases and 2 sales selling 5,121 shares for an estimated $1,130,528.
- MICHAEL DAVID GARRISON (EVP & President, Medical) has made 0 purchases and 2 sales selling 3,435 shares for an estimated $775,007.
- SHANA CAROL NEAL (EVP and Chief People Officer) has made 0 purchases and 3 sales selling 2,575 shares for an estimated $594,550.
- RICHARD BYRD (EVP & President Interventional) has made 0 purchases and 2 sales selling 2,399 shares for an estimated $541,895.
- DAVID SHAN (EVP and Chief ISC Officer) has made 0 purchases and 2 sales selling 2,000 shares for an estimated $450,375.
- JEFFREY WILLIAM HENDERSON purchased 1,500 shares for an estimated $350,430
- BERTRAM L SCOTT sold 700 shares for an estimated $159,593
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$BDX Hedge Fund Activity
We have seen 644 institutional investors add shares of $BDX stock to their portfolio, and 871 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 3,219,317 shares (+36.1%) to their portfolio in Q4 2024, for an estimated $730,366,447
- KOVITZ INVESTMENT GROUP PARTNERS, LLC added 2,722,829 shares (+392.4%) to their portfolio in Q4 2024, for an estimated $617,728,215
- BLACKROCK, INC. added 1,711,450 shares (+7.7%) to their portfolio in Q4 2024, for an estimated $388,276,661
- CITADEL ADVISORS LLC added 1,398,984 shares (+376.2%) to their portfolio in Q4 2024, for an estimated $317,387,500
- BANK OF NEW YORK MELLON CORP removed 1,308,118 shares (-28.6%) from their portfolio in Q4 2024, for an estimated $296,772,730
- PRICE T ROWE ASSOCIATES INC /MD/ removed 1,251,742 shares (-9.2%) from their portfolio in Q4 2024, for an estimated $283,982,707
- BANK OF AMERICA CORP /DE/ added 1,098,633 shares (+77.8%) to their portfolio in Q4 2024, for an estimated $249,246,868
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$BDX Analyst Ratings
Wall Street analysts have issued reports on $BDX in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- UBS issued a "Buy" rating on 12/18/2024
- Evercore ISI issued a "Outperform" rating on 10/01/2024
- Citigroup issued a "Buy" rating on 10/01/2024
To track analyst ratings and price targets for $BDX, check out Quiver Quantitative's $BDX forecast page.
$BDX Price Targets
Multiple analysts have issued price targets for $BDX recently. We have seen 2 analysts offer price targets for $BDX in the last 6 months, with a median target of $282.5.
Here are some recent targets:
- Vijay Kumar from Evercore ISI set a target price of $290.0 on 10/01/2024
- Joanna Wuensch from Citigroup set a target price of $275.0 on 10/01/2024
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
